Home ›› News ›› $2.1 Million Grant Increases Cutting-Edge Clinical Trials

$2.1 Million Grant Increases Cutting-Edge Clinical Trials

Mon 02/25/2013

ORLANDO, Fla., Oct. 10, 2012- The Florida Hospital Cancer Institute (FHCI) has received a three-year, $2.1 million grant from the National Cancer Institute's Community Clinical Oncology Program. This grant will fund NCI-approved clinical trials to be offered to more patients in Central Florida.

As one of the largest federal grants received in Central Florida, FHCI was awarded the grant based on its history of high quality clinical research work. In 2006, FHCI won the Clinical Trial Participation Award from the American Society of Clinical Oncology.

"We are very excited to have the opportunity to expand our clinical trials program," said Dr. Lee Zehngebot, medical director of Clinical Research at Florida Hospital Cancer Institute. "With these funds, we will be able to conduct additional trials that will potentially improve the success of cancer treatment and prevention immensely."

Over the next three years Florida Hospital Cancer Institute will grow the research program to access more phase II and III clinical cancer trials and participate in prevention trials. The funds will be used to hire research personnel and supply state-of-the-art equipment. Patients will be able to participate in cutting-edge cancer clinical trials without leaving the community.

Accessibility to prevention trials is already increasing as a result of the CCOP grant with the launch of four new clinical trials at FHCI CCOP studying:

The effects of nutrition on the spread of prostate cancer
The commonly seen side effect referred to as "sunburn" from breast radiation
The impact of vitamin D on breast density in premenopausal women
The effects of exercise and diet on ovarian cancer survivorship
For more information on clinical trials available at FHCI, call 407-303-2059.

The Community Clinical Oncology Program has been making an impact on cancer research since 1983. It is composed of a group of community hospitals and physicians who participate in NCI-approved cancer prevention, control and treatment clinical trials. There are currently 47 funded CCOP programs in 28 states throughout the county.

For media inquiries only, please contact Florida Hospital Media Relations at 407-303-8217.

*Research reported in this release was supported by the National Cancer Institute of the National Institutes of Health under award number U10CA167730. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Particpating Physicians:

Hematology and Oncology

Adnan Akhtar, MD
Carlos Alemany, MD 
Raul Castillo, MD
Ricardo Crisostomo, MD
Phillip Dunn, MD 
William Grow, MD
Linda Lukman, MD
David Molthrop, MD
Robert Reynolds, MD
David Robinson, MD
Sonalee Shroff, MD
Ahmed Zakari, MD
Lee Zehngebot, MD

Radiation Oncology

Kelly LaFave, MD
Robert J Sollaccio, MD